Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Gastrointest Oncol. Apr 15, 2020; 12(4): 405-423
Published online Apr 15, 2020. doi: 10.4251/wjgo.v12.i4.405
Figure 4
Figure 4 Kaplan-Meier overall survival curves for patients treated with first-line cetuximab versus first-line bevacizumab by primary tumor location in the propensity score–matched sample. 1P value indicates that a significant difference exists across the 4 categories. CI: Confidence interval; LPTL: Left-sided primary tumor location; NA: Not available; OS: Overall survival; RPTL: Right-sided primary tumor location.